Apricitabine: a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infection.
about
The design of drugs for HIV and HCVApricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnaviruses.Intracellular metabolism of the nucleotide prodrug GS-9131, a potent anti-human immunodeficiency virus agent.Comparison of the pharmacokinetics of apricitabine in the presence and absence of ritonavir-boosted tipranavir: a phase I, open-label, controlled, single-centre study.Revealing interaction mode between HIV-1 reverse transcriptase and diaryltriazine analog inhibitor.
P2860
Apricitabine: a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Apricitabine: a novel deoxycyt ...... oside-resistant HIV infection.
@en
type
label
Apricitabine: a novel deoxycyt ...... oside-resistant HIV infection.
@en
prefLabel
Apricitabine: a novel deoxycyt ...... oside-resistant HIV infection.
@en
P2093
P2860
P1476
Apricitabine: a novel deoxycyt ...... oside-resistant HIV infection.
@en
P2093
James Sawyer
Mark A Wainberg
Pedro Cahn
Richard C Bethell
P2860
P356
10.1177/095632020701800201
P577
2007-01-01T00:00:00Z